PUBLIC COMPANY
save$TARSTarsus Pharmaceuticals, Inc.
$TARS73.00-3.26%Irvine, CA, USupdated 1d ago
community read0 votes
pipeline
3
marketed
1
phase 3
0
catalysts ytd
1
approvals ytd
0
recalls ytd
0
Pipeline(3)
pipeline depth3 products
2Phase 21Marketed
Upcoming
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase2A Study to Evaluate Safety and Efficacy of TP-05 in Healthy Participants With Tick Exposure
- phase2Study of Lotilaner Ophthalmic Gel in Patients With Ocular Rosacea (KORE)
- phase2Pilot Study Comparing the Safety and Efficacy of Two Dosing Regimens of TP-03 for the Treatment of MGD
- phase4Impact of XDEMVY® on Demodex Blepharitis in Soft Contact Lens Wearers
- phase2A Human Tick Kill Study to Investigate the Safety, Tolerability, and Whole Blood Concentration of TP-05
- phase1A Six Week Pharmacokinetic Study of TP-03 in Healthy Subjects
- phase2Effect of an Exploratory Vehicle on Meibomian Gland Dysfunction in Patients With Demodex
- phase3Trial to Evaluate the Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis
🐶 Hiring Signal
next earnings Nov 4, 2026
News
- M&A slows in Q3 but Vertex snags one of the year’s biggest in $10B Crinetics buyAfter a frantic second quarter, M&A steadied with just under $30 billion across 22 total transactions, according to a BioSpace analysis.biospace · 2d ago
- Alkeus, an unorthodox eye drug startup, acquired by Tarsus for up to $800MAlkeus brought to late-stage testing a Stargardt disease therapy that former executive chairman and Vertex founder Josh Boger once called, “if it works, the most perfect drug I’ve ever seen.”biopharma_dive · 1mo ago
- ARPA-H puts $160M into bespoke drug therapies; Biohaven switches up scientific leadershipThe ARPA-H program could provide researchers with a roadmap to develop personalized gene editing drugs. Elsewhere, a Botox rival succeeded against migraines and two deals were struck.biopharma_dive · 2mo ago
Data sources
last refreshed 40m ago
Found something off?
comments(0)
5-min edit window · permanent after that